Indonesia

Pt Indofarma Tbk

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Indonesian Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about Pt Indofarma Tbk from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Legal Address
Jl. Indofarma No.1
Cikarang; West Java; Map
Postal Code: 17530

Tel: +62-21-8832-,+62-21-8590-
Fax: +62-21-8832-

Email:
@indofarma.co.id

Website:
http://www.indofarma.co.id

Company Description
PT. Indofarma (Persero) Tbk. (INAF), operates as a state-owned enterprise that produce pharmaceuticals and health products. INAF's products are marketed both domestically and internationally. INAF manufactures and distributes pharmaceuticals products, including ethical and OTC products. INAF also markets and distributes health products. INAF's ethical products include generic medicines and trademarked medicines, while its OTC products are classified into: OTC medicines, herbal medicines and health food. INAF was listed on Indonesia Stock Exchange in 2001 under the Main Board. The company was founded in 1996 and based in Bekasi, West Java, Indonesia.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Basic Information
Total Employees:
1,641 (2012)
Outstanding Shares:
: ()
Financial Auditors:
()
Incorporation Date:
1996
Profile Updated:
January 07, 2018
Key Executives
President
Secretary
Board Member
Board Member
Ownership Details
The Government Of The Republic Of Indonesia
80.66%
Other
Key Financial Highlights
2017 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 1,473,087,697
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO